==== Reference: Usmani SS, Bedi G, Samuel JS, Singh S, Kalra S, Kumar P, et al. (2017) THPdb: Database of FDA-approved peptide and protein therapeutics. PLoS ONE 12(7) e0181748.====

Browse result page of THPdb

The total number entries retrieved from this search are 11
IDThPPIDNamePeptide SequenceLengthFunctional ClassificationDiseaseBrandCompanyPhysical AppearanceRoute of AdministartionCategoryTarget
1033Th1006BivalirudinFPRPGGGGNGDFEEIPEEYL Full view20IaHematological,MetabolicAngioxThe Medicines Company UK LtdPowder for concentrate for solutionInjectionAntithrombins Prothrombin
1151Th1022Antihemophilic FactorATRRYYLGAVELSWDYMQSD Full view255IaHematological,MetabolicHelixate FSN.A.Sterile, stable, purified, nonpyrogenic, dried concentrateIntravenous InjectionCoagulants and Thrombotic agents Coagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
1152Th1022Antihemophilic FactorATRRYYLGAVELSWDYMQSD Full view255IaHematological,MetabolicHemofil MN.A.Dry concentrateIntravenous InjectionCoagulants and Thrombotic agents Coagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
1389Th1062RituximabHeavy Chain: QVQLQQP Full view664IIaCancer/ImmunologicalRituxanBiogen Idec Inc., and Genentech USA, IncSterile, clear, colorless, preservative-free liquid concentrate Intravenous administrationAntineoplastic Agents, Immunologic Factors and Antirheumatic Agents B-lymphocyte antigen CD20,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,Complement C1s subcomponent,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c, Receptor tyrosine-protein kinase erbB-2,Epidermal growth factor receptor,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Complement C1s subcomponent,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor I
1466Th1090DaclizumabQVQLVQSGAEVKKPGSSVKV Full view674IIaImmunologicalsZenapaxRocheClear, sterile, colorless concentrate for further dilution and intravenous administrationIntravenous injectionImmunosuppressive Agents Fusion glycoprotein F0,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c
1584Th1125GolimumabN.A. Full view0IIbImmunologicalSimponi InjectionN.A.Sterile concentrated solution of the golimumab antibodyIntravenous infusionAntipsoriatic Agents and Monoclonal antibodies and TNF inhibitor Tumor necrosis factor
1636Th1142ObinutuzumabN.A. Full view0IIbCancerGazyvaGenentechSterile, clear, colorless to slightly brown, preservative free liquid concentrateIntravenous infusionAntineoplastic Agents B-lymphocyte antigen CD20
1644Th1147NatalizumabN.A.
Full view
0IIaGenetic/ImmunologicalTysabriBiogen Idec Inc.Sterile, colorless, and clear to slightly opalescent concentrateIntravenous infusionImmunosuppressive agents N.A.
1724Th1174DaratumumabNA Full view0IIIcCancerDarzalexJanssen Biotech, Inc.Solution, concentrateIntravenousAntineoplastic Agents ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1
1808Th1200Prothrombin complex concentrateNA Full view0IaHematological DisordersKcentraCsl Behring AgNanofiltered and Lyophilized non-activated four-factor Prothrombin Complex ConcentrateIntravenousNA NA
1829Th1219Anti-thymocyte Globulin (Rabbit)NA Full view0IIIbImmunological DisordersATG-FreseniusGenzyme Inc.Concentrate for solution for infusion. IntravenousAntibody T-cell surface glycoprotein CD1a, Major histocompatibility complex class I-related gene protein, Integrin alpha-L, T-lymphocyte activation antigen CD86, Low affinity immunoglobulin gamma Fc region receptor II-b, T-cell surface glycoprotein CD4, Integrin beta-1, Integrin alpha-V, Integrin beta-3